glp 1 approved for type 1 diabetes on a GLP-1 Drug? Watch Hypoglycemia and DKA Should I take a GLP-1

It has demonstrated positive treatment outcomes for GI tract issues, periodontitis, and lesions of the liver and pancreas

Its decline with age by up to 40 percent between young adulthood and the sixth decade is directly associated with the accumulation of oxidative damage that accelerates virtually every hallmark of ageing

Variety

The CV benefits of these agents are evident at the level of primary prevention of CVDs through controlling CV risk factors, particularly overweight and obesity

they simplify logistics, reduce cold-chain dependencies, and enable more flexible dosing, ultimately enhancing accessibility and compliance